PGY-1

  • Katherine Ghattas, PharmD headshot
    Katherine Ghattas, PharmD
  • Amanda Rawa, PharmD headshot
    Amanda Rawa, PharmD

Current Residents and Recent Graduate Research

YearResidentProjectPost-Residency Employment

2024-2025 
Kelley Maberry 
Outcomes associated with the implementation of a loop diuretic dosing guide in patients presenting to the emergency department with congestive heart failure exacerbation 
Staff Pharmacist, Lancaster General Hospital

2024-2025 
Hanh Motilall 
Outcomes associated with the implementation of a loop diuretic dosing guide in patients presenting to the emergency department with congestive heart failure exacerbation 
Staff Pharmacist, Mt. Pocono Medical

2024-2025 
Connor Quinter 
Outcomes associated with the implementation of a loop diuretic dosing guide in patients presenting to the emergency department with congestive heart failure exacerbation
Clinical Pharmacist, Reading Hospital
2023-2024Mary HoangOutcomes among patients with human immunodeficiency virus (HIV) switched from oral antiretroviral therapy (ART) to long-acting intramuscular (IM) antiretroviral therapy at an HIV clinicStaff Pharmacist, Lehigh Valley Hospital
2023-2024Christina SwigerProvider education and evaluation of patient eligibility for sodium glucose co-transporter 2 (SGLT2) inhibitor usage in heart failure patients to improve utilization and 30-day readmission ratesClinical Pharmacist, Reading Hospital
2023-2024Emily WagnerImplementation of a Pharmacist Initiative for Direct Oral Anticoagulants (DOACs): A Comparison of Appropriate Dosing Inpatient and at DischargeClinical Specialist - Internal Medicine, University of Oklahoma
2023-2024Maley ZentsImpact of a pharmacist led antimicrobial stewardship initiative on the appropriate use of ciprofloxacinClinical Pharmacist - Emergency Medicine, INTEGRIS Health
2022-2023Michael DoEmpagliflozin and dapagliflozin in heart failure with preserved ejection fraction (HFpEF)Clinical Pharmacist, Cencora
2022-2023Elaina LioudisImpact of adding reduced insulin dosing options to the emergency department/inpatient hyperkalemia order-setClinical Pharmacist, Reading Hospital
2022-2023Bona ShinThe impact of a pharmacist led antibiotic stewardship initiative to improve appropriate levofloxacin utilizationPGY-2 Transplant, Johns Hopkins Medicine
2021-2023 (NT)Hope DurhamReadmission rate association with oral step-down therapy versus intravenous therapy for gram negative bloodstream infectionClinical Pharmacist, Reading Hospital
2021-2022Laura AndinoEvaluating the impact of a pharmacy-led initiative to incorporate SGLT2 inhibitors in the prescribing protocol for patients with heart failure with reduced ejection fractionPRN Pharmacist, Reading Hospital
2021-2022Priya RajendranEvaluation of various treatment regimens on hospital length of stay in neonatal abstinence syndrome babies after in-utero exposure to opioidsChristianaCare
2021-2022Lina ShaoRisk of pulmonary toxicity when utilizing granulocyte colony-stimulating factors with bleomycin treatmentPGY-2 Oncology, University of Illinois Chicago
2020-2021Hina AnwarManagement of hyperkalemia with insulin and dextrose using a pharmacist developed order set to identify, monitor, and treat hypoglycemiaPhoenixville Hospital
2020-2021Sophonny HuynhOutcomes of patients with human immunodeficiency virus (HIV) after switching from a three-drug antiretroviral regimen to a two-drug antiretroviral regimen at an HIV clinicChildren’s Hospital of Pennsylvania
2020-2021Bianca NguyenPharmacist assessment of penicillin allergy on aztreonam utilizationUniversity of Pennsylvania
2019-2021 (NT)Tatyana KolyesnikDe-escalation of antibiotics with utilization of BioFire FilmArray Meningitis/Encephalitis Pane 
2019-2021 (NT)Svyatoslav KredensEvaluating the impact of long acting injectable antipsychotics on readmission rates and overall patient outcomesReading Hospital
2019-2020Kristin FeickEvaluation of the impact of a pharmacist managed inpatient warfarin protocolReading Hospital
2019-2020Jumie JacobTherapeutic target attainment with weight-based dosing of enoxaparin for thromboprophylaxis in trauma patientsTower Health
2019-2020Connar JanEvaluation of pharmacist-driven interventions on antibiotic utilization in patients with cellulitis and heart failure 
2018-2019Vincent AnthonyEffect of a pharmacist-led methicillin-resistant Staphylococcus aureus nares PCR screening protocol on duration of vancomycin therapyReading Hospital
2018-2019Rachel SmithFeasibility of therapeutic unfractionated heparin monitoring utilizing anti-factor Xa compared to activated partial thromboplastin timeSpecialty Pharmacist Navigator with AmerisourceBergen - Reading Hospital Ambulatory Pharmacy; Per diem Pharmacist, Reading Hospital
2018-2019Kara StielyEvaluation of the use of bar code medication preparation in sterile compoundingPGY-2 in Ambulatory Care, Allegheny General Hospital
2017-2018Christian ChoImplementation of a sepsis treatment protocol for adult oncology patients and its impact on time to initial antibiotic and fluid administrationPGY-2 in Infectious Diseases, Allegheny General Hospital
2017-2018Dan ElliottPatient care and financial impact of an inpatient therapeutic interchange from inhaler to nebulizer treatmentsPGY-2 in Health-System Pharmacy Administration, Ascension Healthcare
2017-2018Stephanie (Rusin) NunezEvaluation of the safety of patient-controlled analgesia in acute pain managementSpecialty Pharmacist Navigator with AmerisourceBergen - Reading Hospital Ambulatory Pharmacy; Per diem Pharmacist, Reading Hospital
2016-2017Rimmal KhanEvaluating the need for pharmacist-driven counseling of patients with metabolic syndrome in an outpatient psychiatric clinicAmbulatory Care Specialist, Boston Medical Center; PGY-2 in Ambulatory Care. Boston Medical Center
2016-2017Sandra RumyantsevAssessing pharmacist impact on long-term use of proton pump inhibitors in an ambulatory clinicPGY-2 in Critical Care, Carilion Clinic
2016-2017Nissa TasnimOptimizing anticoagulation therapy for the treatment of deep vein thrombosis and pulmonary embolism in a hospital based pharmacist run anticoagulation clinicPer diem pharmacist, Kindred Hospital; Adjunct Faculty/P3 Lab Instructor, University of the Sciences
2015-2016Paul BoylanIncidence of acute kidney injury in patients receiving intravenous vancomycin in combination with piperacillin-tazobactam or cefepimePGY-2 in Transitions of Care, NOVA Southeastern University College of Pharmacy
2015-2016Ken TrinhEvaluation of a heparin infusion protocol dosed using adjusted body weight in acute patients for venous thromboembolism or cardiovascular indicationsPGY-2 in Critical Care, Ascension St. Vincent Hospital
2014-2015Caitlin LozorakDifferences in length of stay in neonatal abstinence syndrome babies after in utero exposure to methadone or buprenorphinePGY-2 in Pediatrics, Palmetto Health Children's Hospital
2014-2015Kemeisha (Taylor) SmithRetrospective review of extended infusion piperacillin/tazobactam in critically ill patientsClinical Pharmacist, ChristianaCare
2013-2014Katie (Stegura) NesbittEffect of a pharmacy-driven medication collection program in the emergency department on length of stay and 30 day readmission ratesReading Hospital
2013-2014Sharnae StevensEffect of liposomal bupivacaine on use of postoperative opioid rescue and opioid related adverse eventsPGY-2 in Critical Care, Baystate Medical Center
2012-2013Vineeta BhojaniEarly conversion of intravenous to oral levetiracetam and its effect on critical care unit length of stay and hospital length of stayReading Hospital
2012-2013Troy GibsonEvaluation of the appropriateness of aldosterone antagonist therapy in heart failure patients with left ventricular systolic dysfunctionReading Hospital